Source of funding and outcome of clinical trials

Davidson, Richard A.·1986·Journal of General Internal Medicine
DOI 10.1007/bf02602327

Cited by (397)

Items 301–397 of 397

  1. Undue Pharmaceutical Industry Influence in Medical Profession
    Anna Laskai · 2020 · Studies of organized crime
  2. CHAPTER THREE. Research Design
    Norman Frohlich, Joe A. Oppenheimer · 1992 · University of California Press eBooks
  3. The Limits of Conventional Justification: Inductive Risk and Industry Bias Beyond Conventionalism
    Miguel Ohnesorge · 2020 · Frontiers in Research Metrics and Analytics
  4. Pharmacy Research Policy and Procedures: New initiative Project in Saudi Arabia
    Yousef Ahmed Alomi, Amal Hassan Al-Najjar · 2022 · International Journal of Pharmacology and Clinical Sciences
  5. Collaboration within Academia and with Industry
    Adil E. Shamoo, David B. Resnik · 2022 · Oxford University Press eBooks
  6. Conflicts of interest in medical practice.
    J. Antunes · 2007 · Advances and technical standards in neurosurgery
  7. (Women and) children first: applicable to lifeboats? Applicable to human experimentation?
    Lainie Friedman Ross, M Justin Coffey · 2002 · PubMed
  8. Financial Conflicts of Interest Worth Knowing
    K. Brad Wray · 2010 · Science
  9. Qualms about Balms: Perspectives on Antidepressants
    Roger P. Greenberg · 2001 · The Journal of Nervous and Mental Disease
  10. La relevancia de las publicaciones de trabajos de investigación con »resultados negativos«
    M. Mestre · 2002 · Revista Clínica Española
  11. Ethical considerations of industry-sponsored research: the use of human subjects.
    Jonathan D. Moreno · 1996 · Journal of the American College of Nutrition
  12. Reply to Sponsored Clinical Trials and Bias
    Alan J. Gelenberg, Marlene P. Freeman · 2007 · The Journal of Clinical Psychiatry
  13. Application of the principles of evidence-based medicine in programs to assess high-cost procedures and medications
    Edimar Alcides Bocchi, José Antônio Marin‐Neto · 2001 · Arquivos Brasileiros de Cardiologia
  14. Deviation Among Technology Reviews: An Informative Enrichment of Technology Evolution Theory for Marketing
    Ashish Sood, Stefan Stremersch · 2010 · RePub (Erasmus University Rotterdam)
  15. Evidence Based Medicine: Making It Better
    Jacob Mammen Puliyel · 2011
  16. Improving Quality of Pharmacoeconomic Studies: Guidelines for Avoiding Bias
    Akira Ohishi, Kevin Alan Schulman · 1998 · Iryo To Shakai
  17. Government and science: stimulation or inhibition.
    Troyen A. Brennan · 1992 · PubMed Central
  18. Industry-Funded Dermatologic Research Within Academia in the United States: Fiscal and Ethical Considerations
    Mary‐Margaret Chren · 1992 · Journal of Investigative Dermatology
  19. Financial Conflicts of Interest and Academic Economists in Law and Policymaking
    Kate Conlow · 2024 · SSRN Electronic Journal
  20. Os MØdicos e a Indœstria FarmacŒutica The Doctors and Pharmaceutical Industry
    Diego Espinheira, Júlio Leonardo, Pereira Barbosa · 2004
  21. International differences in the clinical effectiveness of medical interventions: a study using “panoramic” meta-analysis
    Louise Hartley · 2012 · University of Birmingham Institutional Research Archive (University of Birmingham)
  22. Pharmacoepidemiology and the Law
    A. Kesselheim, K. N. Vokinger · 2019 · Pharmacoepidemiology
  23. Trial Reports: Improving Reporting, Minimizing Bias, and Producing Better Evidence‐Based Practice
    Larissa Shamseer, Lucy Turner, David Moher · 2014 · Wiley eBooks
  24. Ensaios clínicos, conferências de consenso e prática clínica
    Alan D. Sniderman · 2004 · Revista Latinoamericana de Psicopatologia Fundamental
  25. Ethics of Clinical Oncology Research
    Manish Agrawal, Lindsay A. Hampson, Ezekiel J. Emanuel · 2007 · Springer eBooks
  26. O relacionamento acadêmico com a indústria farmacêutica nas ciências da vida
    João Victor Novaretti, Marcelo Marotti · 2004 · Revista da Associação Médica Brasileira
  27. Dr. Bauer Replies
    Mark S. Bauer · 2004 · American Journal of Psychiatry
  28. Sponsored Clinical Trials and Bias
    Adrian Preda · 2007 · The Journal of Clinical Psychiatry
  29. The Assessment of Publication Quality
    Madhav Swaminathan, Barbara G. Phillips‐Bute, Katherine P. Grichnik · 2008 · Anesthesia & Analgesia
  30. Industry Funding and Author-Industry Affiliation in Clinical Trials in Psychiatry
    JOHN H. MONTGOMERY · 2006 · American Journal of Psychiatry
  31. Reply to letters EJCP 2004-0271.R1 and EJCP 2004-0275?response requested by Dr D.N. Bateman, Managing Editor
    E. Ernst, Katja Schmidt · 2005 · European Journal of Clinical Pharmacology
  32. Sociología de la evaluación médica. Problemas metodológicos y contexto socioeconómico de los ensayos clínicos
    Juan Javier Sánchez Carrión · 2013 · Papers Revista de Sociologia
  33. Sertraline Versus Venlafaxine XR in Major Depressive Disorder
    Ana Lusicic, Karuppiah Jagadheesan · 2007 · The Journal of Clinical Psychiatry
  34. Analysing the efficacy of clozapine
    Syed Ahmer · 2004 · The British Journal of Psychiatry
  35. Focus on the activity of local ethic committees in Italy
    Pamela Barbadoro, Massimo Frascarello, Marco Fanesi, Emilia Prospero, Marcello Mario D’Errico · 2008 · Italian Journal of Public Health
  36. History of Clinical Trial Development and the Pharmaceutical Industry
    Jeffrey M. Peppercorn, Thomas G. Roberts, Tim G. Hammond · 2010 · Pharmaceutical Sciences Encyclopedia
  37. Comment on: Ogden T (2009) ‘Data sharing, Federal Rule of Evidence 702, and the Lions in the Undergrowth’
    Barry I. Castleman, Fernand Turcotte, Morris Greenberg · 2010 · The Annals of Occupational Hygiene
  38. Conflicts of interest in biomedical publishing
    Andreas Lundh · 2012
  39. STATE MEDICAL BOARD RESPONSES TO AN INQlJIRY ON PHYSICIAN RESEARCHER MISCONDUCT
    S. Kruszewski, R. Paczynski, M. Bialy · 2008 · Journal of Medical Regulation
  40. From the Editor More Than Meets the Eye—Ethics in Modern Ophthalmology 911
    Ashvini K. Reddy, Thomas A. Oetting · 2010
  41. Conflict Of Interest:an Analysis Of The Efficacy Of Financial Disclosure Policies In Orthopedic Surgery And Professional Schools
    Kolawole A. Jegede · 2011
  42. Evidence-Based Medicine—Can You Trust the Evidence?
    Yvonne M. Buys · 2010 · The AMA Journal of Ethic
  43. Effects of microwave diathermy on signs and symptoms of delayed onset muscle soreness: a systematic review of Japanese primary studies
    Koya Mine, Takashi Nakayama, Steve Milanese, Karen Anne Grimmer · 2015 · Physical Therapy Reviews
  44. Sources: Pharmaceutical Promotion and the Medical Profession: Appendix A
    Lex, Joseph Rohan · 2004 · EngagedScholarship @ Cleveland State University (Cleveland State University)
  45. Partnerships in Biomarker Research
    Gregory J. Downing · 2003 · Drugs and the pharmaceutical sciences
  46. Science and Mammon
    David B. Resnik · 2007
  47. Government Funding of R&D
    David B. Resnik · 2007
  48. Ethical Limits of Science, Especially Economics
    Gereon Wolters · 2016 · BRILL eBooks
  49. Chapter Four Disseminating the Results
    Andrew Thompson, Matthias Egger · 2001
  50. Grant/Project/Contract/Support Information
    Randye J. Semple · 2009
  51. ORIGINAL ARTICLES Association of Industry Sponsorship to Published Outcomes in Gastrointestinal Clinical Research
    Alphonso Brown, Daniel Kraft, Sarah M. Schmitz, Virginia Sharpless, Christopher Martin, Ritesh Kumar Shah, Nicholas J. Shaheen · 2006
  52. The Impact of Source of Funding on the Outcome of Clinical Trials in India
    Benhur Ruqsana · 2018 · Arthaniti-Journal of Economic Theory and Practice
  53. Dr Jekyll and Mr Hyde? Undue Pharmaceutical Industry Influence and the Institutional Corruption of the Medical Profession – A Qualitative Analysis of Industry-Medicine Relationships in Hungary and the Netherlands
    Anna Laskai · 2018 · Eötvös Loránd Tudományegyetem
  54. The downsides of industry-funded development of new therapeutics
    Mir S. Adil, Ruqiya Sultana · 2018 · Indian Journal of Health Sciences and Biomedical Research (KLEU)
  55. A Six-Month Assessment of Medical News Reporting in Leading Local Newspapers in the Philippines: Is It Based on Good Evidence?
    Lalaine Llamido-Mortera, Rosalyn Hernandez-Sebastian, Renato B. Dantes · 2023 · Acta Medica Philippina
  56. 医学研究分野における利益相反問題 : エビデンスに基づく情報学的研究( 情報の信頼性)
    真奈美 榊原, 篤毅 野添 · 2011 · 情報の科学と技術
  57. References
    Jeremy Howick · 2011 · Wiley eBooks
  58. Conclusion
    David B. Resnik · 2007
  59. Publication
    David B. Resnik · 2007
  60. Research Policy on Case-control and Cohort Study Design in Pharmaceutical Care
    Yousef Ahmed Alomi, Amal Hassan Al-Najjar, Maha Hussein Almadany, Fakhar Al-Ayoubi, Ghudair Tashan Alanazi, Abeer Hussin Almasoudi · 2022 · International Journal of Pharmacology and Clinical Sciences
  61. Research Policy of the Research Data Management in Pharmacy Practice
    Yousef Ahmed Alomi, Amal Hassan Al-Najjar, Hamidah Qasim Ali Abushomi, Maha Hussein Almadany, Abeer Hussin Almasoudi · 2022 · International Journal of Pharmacology and Clinical Sciences
  62. Research Policy on Pharmacy Investigational Medication
    Yousef Ahmed Alomi, Amal Hassan Al-Najjar, Hamidah Qasim Ali Abushomi, Maha Hussein Almadany, Abeer Hussin Almasoudi · 2022 · International Journal of Pharmacology and Clinical Sciences
  63. Research Policy of the Investigational Drugs in the Clinical Trial
    Yousef Ahmed Alomi, Amal Hassan Al-Najjar, Hamidah Qasim Ali Abushomi, Maha Hussein Almadany, Abeer Hussin Almasoudi · 2022 · International Journal of Pharmacology and Clinical Sciences
  64. Research Policy of the Institutional Review Board in Pharmacy Practice
    Yousef Ahmed Alomi, Amal Hassan Al-Najjar, Hamidah Qasim Ali Abushomi, Maha Hussein Almadany, Abeer Hussin Almasoudi · 2022 · International Journal of Pharmacology and Clinical Sciences
  65. Intellectual Property
    David B. Resnik · 2007
  66. «Disclosure helps /but is not a panacea». Zu rechtlichen Rahmenbedingungen medizinischer Forschung und Bildung in der Schweiz
    2002 · Bulletin des Médecins Suisses
  67. Ethical Issues Before the Study Begins
    2005 · Kluwer Academic Publishers eBooks
  68. Research Design
    Andrew Thompson, Norman Joseph Temple · 2001 · Springer eBooks
  69. «Disclosure helps/but is not a panacea». Concernant les conditions cadres juridiques de la recherche et de la formation médicales en Suisse
    2002 · Bulletin des Médecins Suisses
  70. Conflicts of Interest
    David B. Resnik · 2007
  71. Rebuttal
    Lorraine E. Ferris · 2004 · Canadian Medical Association Journal
  72. Número complet
    Equip De redacció · 2013 · Papers Revista de Sociologia
  73. The Use of Animals in Research
    Adil E. Shamoo, David B. Resnik · 2022 · Oxford University Press eBooks
  74. Scientific Research and Ethics
    Adil E. Shamoo, David B. Resnik · 2022 · Oxford University Press eBooks
  75. Authorship
    Adil E. Shamoo, David B. Resnik · 2022 · Oxford University Press eBooks
  76. Data Acquisition and Management
    Adil E. Shamoo, David B. Resnik · 2022 · Oxford University Press eBooks
  77. Conclusion
    Adil E. Shamoo, David B. Resnik · 2022 · Oxford University Press eBooks
  78. Mentoring and the Research Environment
    Adil E. Shamoo, David B. Resnik · 2022 · Oxford University Press eBooks
  79. The Protection of Human Subjects in Research
    Adil E. Shamoo, David B. Resnik · 2022 · Oxford University Press eBooks
  80. Intellectual Property
    Adil E. Shamoo, David B. Resnik · 2022 · Oxford University Press eBooks
  81. Science and Social Responsibility
    Adil E. Shamoo, David B. Resnik · 2022 · Oxford University Press eBooks
  82. Research Policy on Cross-Sectional Studies in Pharmacy Practice
    Yousef Ahmed Alomi, Amal Hassan Al-Najjar, Ghudair Tashan Alanazi, Maha Hussein Almadany, Abeer Hussin Almasoudi · 2022 · International Journal of Pharmacology and Clinical Sciences
  83. Research Policy of Case Report and Case Series Design
    Yousef Ahmed Alomi, Amal Hassan Al-Najjar, Esraa Altawil, Maha Hussein Almadany, Ghudair Tashan Alanazi, Abeer Hussin Almasoudi · 2022 · International Journal of Pharmacology and Clinical Sciences
  84. Education and Training Research Policy in Pharmacy Practice
    Yousef Ahmed Alomi, Amal Hassan Al-Najjar, Maha Hussein Almadany, Abeer Hussin Almasoudi · 2022 · International Journal of Pharmacology and Clinical Sciences
  85. Research Policy on Research Pharmacist Competency
    Yousef Ahmed Alomi, Amal Hassan Al-Najjar, Maha Hussein Almadany, Abeer Hussin Almasoudi · 2022 · International Journal of Pharmacology and Clinical Sciences
  86. Research Quality Management Policy
    Yousef Ahmed Alomi, Amal Hassan Al-Najjar, Maha Hussein Almadany, Abeer Hussin Almasoudi · 2022 · International Journal of Pharmacology and Clinical Sciences
  87. Research Policy: Narrative Review in Pharmacy Practice
    Yousef Ahmed Alomi, Amal Hassan Al-Najjar, Maha Hussein Almadany, Abeer Hussin Almasoudi · 2022 · International Journal of Pharmacology and Clinical Sciences
  88. Copyright Page
    2007
  89. Abbreviations
    2007
  90. Dedication
    2007
  91. The Value of Scientific Publications in Surgical Device Innovation
    Alfred Song, Stefano Rensi, Abigail G. Tarquinio, Eli M. Cahan, Vivian de Ruijter, James Kennedy Wall · 2022 · Surgical Innovation
  92. Preface to the Fourth Edition
    Adil E. Shamoo, David B. Resnik · 2022 · Oxford University Press eBooks
  93. Copyright Page
    Adil E. Shamoo, David B. Resnik · 2022 · Oxford University Press eBooks
  94. Conflict of interest
    Diego Laurentino Lima, Carlos André Balthazar da Silveira, Ana Caroline Dias Rasador, Raquel Nogueira · 2025 · Elsevier eBooks
  95. Preparativos para la redacción de un manuscrito
    F. García Río · 2010 · Elsevier eBooks
  96. Additional file 1 of Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients
    Arman Shafiee, Teymouri Athar, Mohammad Mobin, Kohandel Gargari, Omid, Kyana Jafarabady, Sepehr Siahvoshi, Mozhgani, Sayed-Hamidreza · 2022 · Figshare
  97. Outcomes of a Trial of HIV-1 Immunogen in Patients With HIV Infection
    Donald M. Poretz · 2001 · JAMA